Pharmacopeia
CWP-0217
PROMETHAZINE
Gastrointestinal · Gastrointestinal · Level 3
Core pharmacology
- Class Group
Anti-emetic
Histamine Antagonist
- Legacy Cicm Level
Level 3
- Introduction
H1-antagonist
- Mechanism of action
1. H1 antagonism- VC, vestibular nucleus and CTZ
2. Anti-muscarinic effects- NTS, CTZ, vomit center
3. D2 antagonism (GIT, CTZ)
5-HT3 antagonist- Physiological effects
CVS- IV may cause transient hypotension
CNS- potent sedative and anxiolytic
GIT- decreased LOS tone
- Adverse Effects Toxicity
1. Over sedation
2. Paradoxical hyper excitability
3. Anticholinergic
4. Photosensitivity
Jaundice- Absorption
Extensive FPM
- Protein binding
93% PB
- Volume of distribution
Vd 2.5L/kg
- Metabolism
Hepatic conjugation and N-dealkylation
- Excretion
2% unchanged in urine.
- Half-life
T1/2=7.5-10 hours